Prehospital pulse-dose glucocorticoid on index of microvascular resistance in patients with ST-segment elevation myocardial infarction: a sub-study of the PULSE-MI trial
Open Access
- 18 March 2025
- journal article
- research article
- Published by Springer Nature in Journal of Inflammation
- Vol. 22 (1) , 1-10
Abstract
Microvascular injury in patients with ST-segment elevation myocardial infarction (STEMI) occurs in up to 50%, yet no therapeutic target exists. Inflammation contributes directly to myocardial damage in STEMI and may also cause deleteriously effects on the microcirculation. The aim of this prespecified sub-study was to determine the effect of prehospital pulse-dose glucocorticoid on the microcirculation determined by index of microvascular resistance (IMR) and its relation to inflammation. The PULSE-MI trial was a 1:1 randomized, blinded, placebo-controlled clinical trial in patients with STEMI transferred for primary percutaneous coronary intervention (PCI) investigating the cardioprotective effects of prehospital pulse-dose glucocorticoid (methylprednisolone 250 mg) compared with placebo. In this prespecified sub-study, we investigated microvascular function as IMR by thermodilution after primary PCI and inflammation defined by C-reactive protein (CRP) at 24 hours after onset of STEMI. Of 530 patients included in the PULSE-MI trial, 295 (56%) were assessed with coronary physiology of whom 142 (48%) were treated with glucocorticoid and 153 (52%) with placebo. Baseline characteristics were overall well-balanced in both groups. The median IMR in the glucocorticoid group was 23 (interquartile range (IQR), 11-38) and 18 (IQR, 11-42) in the placebo group (p=0.49). CRP upon arrival did not differ between treatment groups (p=0.81), but CRP at 24 hours was significantly lower in the glucocorticoid group compared to placebo (p<0.001). Prehospital glucocorticoid did not impact IMR assessed immediately after primary PCI, albeit this compound, demonstrated significant anti-inflammatory effects as determined by CRP levels at 24 hours. http://www.clinicaltrials.gov ; Unique Identifier: NCT05462730.Keywords
Funding Information
- Copenhagen University
This publication has 27 references indexed in Scilit:
- Prehospital Pulse-Dose Glucocorticoid in ST-Segment Elevation Myocardial InfarctionJAMA Cardiology, 2024
- The Index of Microcirculatory Resistance After Primary PCIJACC: Cardiovascular Interventions, 2023
- Intramyocardial Hemorrhage and the “Wave Front” of Reperfusion Injury Compromising Myocardial SalvageJACC, 2022
- Index of Microcirculatory Resistance as a Tool to Characterize Microvascular Obstruction and to Predict Infarct Size Regression in Patients With STEMI Undergoing Primary PCIJACC: Cardiovascular Imaging, 2019
- Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial InfarctionJACC: Cardiovascular Imaging, 2018
- Absolute coronary blood flow measurement and microvascular resistance in ST-elevation myocardial infarction in the acute and subacute phaseCardiovascular Revascularization Medicine, 2016
- Assessment of the acute effects of glucocorticoid treatment on coronary microembolization using cine, first-pass perfusion, and delayed enhancement MRIJournal of Magnetic Resonance Imaging, 2015
- Prognostic Value of Microvascular Obstruction and Infarct Size, as Measured by CMR in STEMI PatientsJACC: Cardiovascular Imaging, 2014
- The relation between hypointense core, microvascular obstruction and intramyocardial haemorrhage in acute reperfused myocardial infarction assessed by cardiac magnetic resonance imagingEuropean Radiology, 2014
- Non-genomic effect of glucocorticoids on cardiovascular systemPflügers Archiv - European Journal of Physiology, 2012